Gilead Sciences
GILD
#129
Rank
โ‚น15.684 T
Marketcap
โ‚น12,633
Share price
0.40%
Change (1 day)
28.71%
Change (1 year)

Operating Margin for Gilead Sciences (GILD)

Operating Margin as of July 2026 (TTM): 36.07%

According to Gilead Sciences's latest financial reports and stock price the company's current Operating Margin is 36.07%. At the end of 2025 the company had an Operating Margin of 33.27%.

Operating Margin history for Gilead Sciences from 2001 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
202533.27%1286.53%
20242.40%-90.51%
202325.30%18.69%
202221.31%-29.7%
202130.32%348.47%
20206.76%-70.59%
201922.99%-34.79%
201835.25%-31.98%
201751.82%-7.89%
201656.26%-15.22%
201566.36%11.18%
201459.69%58.89%
201337.56%0.9%
201237.23%-14.49%
201143.54%-11.56%
201049.23%-1.43%
200949.95%-0.29%
200850.09%-6.67%
200753.67%-354.49%
2006-21.09%-136.82%
200557.28%15.58%
200449.56%-356.71%
2003-19.30%-222.77%
200215.72%-36.02%
200124.57%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Johnson & Johnson
JNJ
34.58%-4.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
12.01%-66.70%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
9.51%-73.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
43.07% 19.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
24.41%-32.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
16.33%-54.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
25.00%-30.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
38.68% 7.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
32.40%-10.17%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.